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A commentary on
Non-biased enrichment does not improve
quantitative proteomic delineation of
reovirus T3D-infected HeLa cell protein
alterations
by Jiang, J., Opanubi, K. J., and Coombs,
K. M. (2012). Front. Microbio. 3:310. doi:
10.3389/fmicb.2012.00310
In this special Frontiers in Microbiology
issue focusing on “Global host proteomic
responses to virus infection,” Coombs and
colleagues (Jiang et al., 2012) make a
valiant effort to look deeper into (changes
in) the proteome of HeLa cells upon
reovirus infection. Using some of the lat-
est proteomic techniques, they present a
high quality analysis of quantified alter-
ations in the protein content of HeLa cells
with, or without, infection by reovirus
T3D. The study of the relatively harmless
mammalian reoviruses received a boost
from their potential to selectively kill cer-
tain types of cancer cells (Coffey et al.,
1998). Proteomic studies, comparing all
proteins and their post translational mod-
ifications in a quantitative fashion between
control and reovirus infected cells there-
fore became crucial. However, all pro-
teomic studies are hampered by the large
differences in natural protein concentra-
tions. In mass spectrometric (ms) prac-
tice, themost conspicuous protein restricts
the level of detection to proteins that
are, at most, about a thousand fold less
abundant. Methods used to overcome this
limitation either purge the most abun-
dant, or specifically purify the less abun-
dant proteins. Of course such biased
approaches have rather big drawbacks
themselves, related to the method of purg-
ing and the choice of purification proce-
dure. “Unbiased” approaches, leveling the
playing field without prior loss of possibly
interesting proteins or enrichment based
on known interactions, come in two fla-
vors. One of them is based on the use of
antibodies against “every” proteinmade by
a certain organism as illustrated by human
tissue profiling (Uhlen and Ponten, 2005).
This is a non-ms technique, although
immune precipitations can be combined
with further ms analysis. The technique
would indeed allow sensitive detection of
very low abundant proteins, but relies on
getting an effective epitope for every gene
product and is rather costly. It also has to
focus on the most common protein form
and will be difficult to use for the detec-
tion of less abundant forms, let alone post
translational modifications.
The only really unbiased approach
available seems to be the use of hexapep-
tide combinatorial ligand libraries to
enrich for all low abundant proteins
(Boschetti and Righetti, 2008). The basic
idea is simple and rather elegant: generate
“random” peptide libraries, coat individ-
ual beads with single peptide forms, and
allow your protein sample to interact with
complex beads mixtures. Highly abundant
proteins will saturate the beads they inter-
act with quickly, and the large unbound
majority will be washed away. However,
proteins that are much less abundant will
also find peptide targets to their liking
and be retained. To give a somewhat more
precise description: the abundance advan-
tage of certain proteins (differences in
mol L−1) has to bemore than compensated
for by differing binding affinities (again in
mol L−1). Prior work showed hexapeptide
libraries (with a combinatorial complexity
of 6.4 × 107 peptides) to be optimal in this
respect. Of course, not all amino acids in
the hexamers contribute to the (strength
of) interaction with proteins in the sample
equally, three hydrophobic ones (Phe, Trp,
and Tyr) and the three basic ones (Arg,
His, and Lys) presumably being the most
important. This (ProteoMiner) technique
is the one that Jiang et al. decided to use.
However, in their abstract it is concluded
that: “Comparisons of the r2 correlations,
degree of dataset overlap, and numbers of
peptides detected suggest that non-biased
enrichment approaches may not provide
additional data to allow deeper quanti-
tative and comparative mining of com-
plex proteomes.” It is refreshing that these
authors highlight what could be seen as
a “negative” finding. In presenting evi-
dence suggesting that in this case non-
biased enrichment strategies do not seem
to allow us to delve much deeper into the
proteome, the authors give us the latest
installment in an ongoing saga regard-
ing the effectivity of using a ProteoMiner
approach to get a peek at low abun-
dant proteins in an unbiased fashion. The
approach has already been used extensively
in one of the most important, but at the
same time most challenging, areas of clini-
cal research: biomarker discovery in serum
(which has tremendous differences in pro-
tein abundancies at ∼1010 differences in
concentration). Discussions regarding the
effectivity of using hexamers seem to have
been resolved in favor of the approach,
although peptide elution had to be per-
formed at three separate pH values to get
full peptide diversity (Bandow, 2010; Di
Girolamo et al., 2011). In regards to cellu-
lar extracts, an extreme example of protein
“imbalance” is found in erythrocytes with
98% hemoglobin. The 2% that remains
was much more easily explored upon the
use of two different hexamer peptide sets
(Roux-Dalvai et al., 2008). Even more
striking are the results obtained by Yates
and colleagues using “normal” Hela cells:
they obtain improvements in silverstained
2D gels as well as statistically significant
differences in proteome sets usingms anal-
ysis of fractions with or without prior
ProteoMiner beads incubation (Fonslow
et al., 2011).
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So what is going on in the case of these
reovirus infected HeLa cells? Actually,
the conflicting data can presumably be
resolved by highlighting the following two
points:
1. As in the case of the earlier discussion,
the elution method seems to be crucial.
The ProteoMiner elution buffer used by
the Yates group for the 2D silverstained
gels is identical to the one used by Jiang
et al., but they digest their proteins on
the beads upon 8 M urea denaturation
for further ms analysis (Fonslow et al.,
2011). For the differences in 2D analysis
followed by silverstaining, the normal
protocol seems to be sufficient, but for
efficient mass analysis more harsh con-
ditions are clearly needed. For more
important insights regarding the use
of ProteoMiner beads as a powerful
method of proteome equalization see
Righetti et al. (2012).
2. Based on the fact that comparisons of
r2 correlations, dataset overlaps, and
numbers of peptides detected were
comparable to those found with bio-
logical replicates the authors were cor-
rect in stating that the enrichment
approach did not provide a significant
deeper quantitative mining of the pro-
teome under study. However, looking at
the Venn diagram of shared and spe-
cific proteins found in different exper-
iments (Jiang et al., Figure 3A), I am
convinced that future analysis of the
“extra” groups of proteins found with
the hexameric non-biased enrichment
approaches in the nuclear and cytoplas-
mic fractions will show them to contain
more low abundant proteins than the
controls.
Indeed, future experiments to check for
improvement in detection of low abun-
dant proteins should again be performed
with virus infected cells. These systems are
especially suited for such an analysis as
they contain a specific set of viral pro-
teins that are completely absent from con-
trol cells, thus functioning as ideal positive
controls. Not only that, many viruses have
a pronounced dynamic range of viral pro-
tein (form)s of their own, making the chal-
lenge of a correct quantitative proteomic
description even bigger. Despite not always
living up to their full potential yet, random
hexapeptide libraries seem to be on track
to level the proteomic playing field in the
near future.
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